Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. 22 Nov Dr D Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.